Drug class in one race

Cardiac cell therapy drugs for Heart Failure

9 tracked Cardiac cell therapy drugs in the Heart Failure race. The class explanation lives on the Cardiac cell therapy page; the full indication pipeline across every mechanism is on the Heart Failure page.

2 Phase 32 Phase 22 Phase 1/23 Phase 1

Head-to-head evidence: ADR-002K vs Anhui HygeianCells EE001 · ADR-002K vs CardiAMP · ADR-002K vs HiCM-188 (allogeneic iPSC-cardiomyocytes) · Anhui HygeianCells EE001 vs CardiAMP · Anhui HygeianCells EE001 vs HS-001 · Anhui HygeianCells EE001 vs HiCM-188 (allogeneic iPSC-cardiomyocytes)

The roster

← all Cardiac cell therapy drugs